The FDA has halted U.S. enrollment…
The FDA has halted U.S. enrollment for Newron Pharmaceuticals’ phase [...]
The FDA has halted U.S. enrollment for Newron Pharmaceuticals’ phase [...]
Immunology med Skyrizi charted sales growth of 30.9% over 2026’s [...]
AstraZeneca has announced it will resume a £300 million investment [...]
Teva Pharmaceuticals has struck a deal to buy Emalex Biosciences [...]
Novartis CEO Vas Narasimhan says that Europe needs a “complete [...]
Pfizer now anticipates its Vyndamax sales to remain “relatively stable” [...]
The FDA has released briefing documents detailing its concerns for [...]
The FDA today announced a new initiative to allow its [...]
The FDA has told Amgen that it is proposing to withdraw [...]
After mulling its options for the past few months, Protagonist [...]